☆ 4.6 Article

Fibrates and the risk of cardiovascular outcomes in chronic kidney disease patients

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Medicine, General & Internal

The Effect of Fibrates on Kidney Function and Chronic Kidney Disease Progression: A Systematic Review and Meta-Analysis of Randomised Studies

Alexandros Hadjivasilis et al.

Summary: The aim of this study was to evaluate the effects of fibrates on kidney disease progression and proteinuria. The results showed that fibrates can improve albuminuria in patients with and without diabetes, and the modest increase in creatinine should not be a limiting factor for initiating fibrate treatment in individuals with preserved renal function or mild chronic kidney disease. However, further research is needed to determine the long-term effects on kidney disease progression.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Aruna Das Pradhan et al.

Summary: In patients with type 2 diabetes and high triglyceride levels, pemafibrate can reduce triglyceride, VLDL cholesterol, remnant cholesterol, and apolipoprotein C-III levels, but does not lower the incidence of cardiovascular events.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study

Wen-Yu Ho et al.

Summary: This study investigated the cardiovascular protective effects of fibrates in patients with end-stage renal disease (ESRD). The results showed that fibrates, whether used alone or in combination with statins, did not reduce mortality or cardiovascular risks in ESRD patients.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

添加到收藏夹

Review Oncology

Overview of the ethical guidelines for medical and biological research involving human subjects in Japan

Junko Eba et al.

Summary: The new national guidelines for clinical research, the Ethical Guidelines for Medical and Biological Research Involving Human Subjects, were implemented in Japan in June 2021. These guidelines integrate previous ethical guidelines and introduce new changes to facilitate research.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk Among Patients With Advanced CKD

Chieh-Li Yen et al.

Summary: This study found that among advanced CKD patients, the use of fenofibrate and statins can reduce the risk of cardiovascular death, while fenofibrate can also reduce the incidence of permanent dialysis.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

添加到收藏夹

Review Peripheral Vascular Disease

Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases

Shizuya Yamashita et al.

CURRENT ATHEROSCLEROSIS REPORTS (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

Francois Mach et al.

ATHEROSCLEROSIS (2019)

添加到收藏夹

Article Endocrinology & Metabolism

Effects of Pemafibrate, a Novel Selective PPAR alpha Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial

Eiichi Araki et al.

DIABETES CARE (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor alpha modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial

Shun Ishibashi et al.

JOURNAL OF CLINICAL LIPIDOLOGY (2018)

添加到收藏夹

Article Peripheral Vascular Disease

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

Makoto Kinoshita et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)

添加到收藏夹

Article Peripheral Vascular Disease

Predicting Coronary Heart Disease Using Risk Factor Categories for a Japanese Urban Population, and Comparison with the Framingham Risk Score: The Suita Study

Kunihiro Nishimura et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2014)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Selective peroxisome proliferator-activated receptora modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists

Jean-Charles Fruchart

CARDIOVASCULAR DIABETOLOGY (2013)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effects of Fibrates in Kidney Disease

Min Jun et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)

添加到收藏夹

Review Urology & Nephrology

Atherosclerosis in CKD: differences from the general population

Tilman B. Drueeke et al.

NATURE REVIEWS NEPHROLOGY (2010)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.

Lukasz Januszkiewicz

KARDIOLOGIA POLSKA (2010)

添加到收藏夹

Article Medicine, General & Internal

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

Henry N. Ginsberg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.